New magnetosensitive nanostructured materials: current status and research prospects
DOI:
https://doi.org/10.15407/hftp17.01.037Keywords:
nanostructures, core-shell nanocomposites, nanorobot functions, magnetic adsorbents, antitumor therapy, photopharmacology, magnetic fluids, interaction with electromagnetic radiationAbstract
The review analyzes and summarizes the results of research covering a wide range of topical issues in chemistry, physics, medicine (in particular oncology), photopharmacology, biology, and ecology.
Examples of promising developments for practical use are considered, related to the chemical design of multi-level core-shell nanocomposites with the functions of medical and biological nanorobots. An example of a structural model of a nanocomposite is given, which includes four hierarchical levels, namely: core – a single-domain magnetite nanoparticle (1), shell – chemically modified surface of the core (2), immobilized biofunctionalized layer (3) and nanocapsule (4).
A new generation of magnetic adsorbents with different surface properties for medical, technical, technological, and environmental applications has been developed and presented. New magnetic fluids based on physiological solution, containing magnetosensitive multifunctional nanocomposites with relevant antitumor drugs and antibodies have been developed. A nanotechnological basis has been developed for minimally invasive methods of photodynamic antitumor therapy and non-invasive controlled pharmacological effects of a given direction on biological cell systems, etc.
The identified features of the developed magnetic fluids include the synergistic antitumor action of their active components and the overcoming of drug resistance in malignant cells and tumors. The example of MR based on physiological fluid, magnetite, and cisplatin shows that, according to general and biochemical blood indicators, it does not have a more toxic effect on the body compared to the official antitumor drug cisplatin in traditional use.
X-ray luminescent nanostructures can be used in photodynamic antitumor therapy as part of magnetite-lanthanum fluoride nanocomposites for controlled targeted delivery of a photosensitive pharmacological drug and its fixation in the body, while those integrated into a bioactive ceramic medium can be used in bone surgery complicated by tumor processes.
The promising prospects of new effective protective materials capable of absorbing electromagnetic radiation in specified spectral ranges for use in electronics and combating electromagnetic smog are demonstrated, as well as the creation of coatings active in the infrared and ultra-high frequency ranges of the spectrum. Broadband absorption and transmission in this case are important factors determining the operational suitability of materials.
References
1. Dey S., Fan C., Gothelf K.V., Li J., Lin C., Liu L., Liu N., Nijenhuis M.A., Sacc? B., Simmel F.C. DNA origami. Nat. Rev. Methods Primers. 2021. 1(1): 1. https://doi.org/10.1038/s43586-020-00009-8
2. Knappe G.A., Wamhoff E.-C., Bathe M. Functionalizing DNA origami to investigate and interact with biological systems. Nat. Rev. Mater. 2022. 8(2): 123. https://doi.org/10.1038/s41578-022-00517-x
3. Geary C., Grossi G., McRae E.K.S., Rothemund P.W.K., Andersen E.S. RNA origami design tools enable cotranscriptional folding of kilobase-sized nanoscaffolds. Nat. Chem. 2021. 13(6): 549. https://doi.org/10.1038/s41557-021-00679-1
4. Ibusuki R., Morishita T., Furuta A., Nakayama S., Yoshio M., Kojima H., Oiwa K., Furuta K. Programmable molecular transport achieved by engineering protein motors to move on DNA nanotubes. Science. 2022. 375(6585): 1159. https://doi.org/10.1126/science.abj5170
5. Meyer T.A., Zhang C., Bao G., Ke Y. Programmable assembly of iron oxide nanoparticles using DNA origami. Nano Lett. 2020. 20(4): 2799. https://doi.org/10.1021/acs.nanolett.0c00484
6. Ji T., Shi H., Yang X., Li H., Kaplan D.L., Yeo J., Huang W. Bioinspired Genetic and Chemical Engineering of Protein Hydrogels for Programable Multi-Responsive Actuation. Adv. Healthcare Mater. 2024. 13(27): 2401562. https://doi.org/10.1002/adhm.202401562
7. Quan M.C., Mai D.J. Biomolecular Actuators for Soft Robots. Chem. Rev. 2025. 125(10): 4974. https://doi.org/10.1021/acs.chemrev.4c00811
8. Cogal G.C., Das P.K., Karaca G.Y., Bhethanabotla V.R., Oksuz A.U. Fluorescence Detection of miRNA-21 Using Au/Pt Bimetallic Tubular Micromotors Driven by Chemical and Surface Acoustic Wave Forces. ACS Appl. Bio Mater. 2021. 4(11): 7932. https://doi.org/10.1021/acsabm.1c00854
9. Yang Y., Arque X., Patino T., Guillerm V., Blersch P.-R., Perez-Carvajal J., Imaz I., Maspoch D., Sanchez S. Enzyme-Powered Porous Micromotors Built from a Hierarchical Micro- and Mesoporous UiO-Type Metal-Organic Framework. J. Am. Chem. Soc. 2020. 142(50): 20962. https://doi.org/10.1021/jacs.0c11061
10. Chena G., Zhua F., Gana A.S.J., Mohanb B., Deyc K. K., Xud K., Huanga G., Cuia J., Soloveva A.A., Meia Y. Towards the next generation nanorobots. Next Nanotechnology. 2023. 2: 100019. https://doi.org/10.1016/j.nxnano.2023.100019
11. Tang D., Peng X., Wu S., Tang S. Autonomous Nanorobots as Miniaturized Surgeons for Intracellular Applications. Nanomaterials. 2024. 14(7): 595. https://doi.org/10.3390/nano14070595
12. Levy L., Sahoo Y., Earl B.J. Nanochemistry:? Synthesis and Characterization of Multifunctional Nanoclinics for Biological Applications. Chem. Mater. 2002. 14(9): 3715. https://doi.org/10.1021/cm0203013
13. Horobets S.V., Horobets O.Iu., Horbyk P.P., Uvarova I.V. Functional bio- and nanomaterials for medical use. (Kyiv: Condor, 2018). [in Ukrainian].
14. Horbyk P.P., Makhno S.M., Prokopenko S.L., Lisova O.M., Mazurenko R.V., Turanska S.P., Hunia H.M., Oliinyk K.A., Zhyvets Yu.M. New special materials and coatings that effectively absorb electromagnetic ultra-high frequency and infrared radiation. Ozbroiennia ta viiskova tekhnika. 2023. 2(38): 94. [in Ukrainian].
15. Roco M.C., Williams R.S., Alivisatos P. Vision for Nanotechnology R&D in the Next Decade. V. 156 (Dordrecht: Kluwer Academic Publishers, 2002). P. 171.
16. Androshchuk H.O., Yamchuk A.V., Berezniak N.V., Kvasha T.K., Musina L.A., Novitska H.V. Nanotechnologies in the 21st century: strategic priorities and market approaches to implementation. (Kyiv: UkrINTEI, 2011). P. 272. [in Ukrainian].
17. Kovtunenko O.L., Bohucharskyi V.V., Sliusar V.I., Fedorov P.M. Unconventional weapons: Current status and main trends in development. Protection against them. (Kyiv: TsNDI OVT ZSU, 2004). P. 220. [in Ukrainian].
18. Poplavko Yu.M. Physics of Dielectrics. (Kyiv: NTUU "KPI", 2015). P. 572. [in Ukrainian].
19. Poplavko Yu.M. Basics of physics of magnetic phenomena in crystals. (Kyiv: NTUU "KPI", 2004). P. 227. [in Ukrainian].
20. Borysov O.V. The basics of solid-state electronics. (Kyiv: Osvita Ukrainy, 2004). P. 462. [in Ukrainian].
21. Chekhun V.F., Lukianova N.Y., Todor I.M., Storchai D.M., Borikun T.V., Naleskina L.A., Kusyak A.P., Petranovska A.P., Horbyk P.P. Pharmacokinetics and Biological Effects of Ferromagnetic Nanocomposite in Rats with Sensitive and Ddp-Resistant Guerin's Carcinoma. Toxicology and Applied Pharmacology Insights. 2018. 1(1): 1.
22. Ishikawa T., Wright C.D., Ishizuka H. GS-X pump is functionally overexpressed in cisdiamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem. 1994. 269(46): 29085. https://doi.org/10.1016/S0021-9258(19)62016-8
23. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003. 22: 7265. https://doi.org/10.1038/sj.onc.1206933
24. Yang P., Ebbert J.O., Sun Z., Weinshilboum R.M. Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. J. Clin. Oncol. 2006. 24(11): 1761. https://doi.org/10.1200/JCO.2005.02.7110
25. Stewart D.J. Mechanisms of resistance to cisplatin and carboplatin. Crit. Rev. Oncol. Hematol. 2007. 63(1): 12. https://doi.org/10.1016/j.critrevonc.2007.02.001
26. Chekhun V.F., Lukyanova N.Yu., Burlaka A.P., Bezdenezhnykh N.A., Shpyleva S.I., Tryndyak V.P., Beland F.A., Pogribny I.P. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. Int. J. Oncol. 2013. 43: 1481. https://doi.org/10.3892/ijo.2013.2063
27. Shevchenko A.I., Kolesnik A.P., Kadzhoian A.V., Kuzmenko V.A. Chemoresistance factors in non-small cell lung cancer. Pathologia. 2016. 1(36): 4. [in Russian]. https://doi.org/10.14739/2310-1237.2016.1.71945
28. Zhou J., Kang Y., Chen L., Wang H., Liu J., Zeng S., Yu L. The drug-resistance mechanisms of five platinum-based antitumor agents. Front. Pharmacol. 2020. 11(343): 1. https://doi.org/10.3389/fphar.2020.00343
29. Prylutska S., Politenkova S., Afanasieva K., Korolovych V., Bogutska K., Sivolob A., Skivka L., Evstigneev M., Kostjukov V., Prylutskyy Y., Ritter U. A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity. Beilstein. J. Nanotechnol. 2017. 8: 1494. https://doi.org/10.3762/bjnano.8.149
30. Grebinyk A., Prylutska S., Buchelnikov A., Tverdokhleb N., Grebinyk S., Evstigneev M., Matyshevska O., Cherepanov V., Prylutskyy Y., Yashchuk V., Naumovets A., Ritter U., Dandekar T., Frohme M. C60 fullerene as an effective nanoplatform of alkaloid berberine delivery into leukemic cells. Pharmaceutics. 2019. 11(11): 586. https://doi.org/10.3390/pharmaceutics11110586
31. Grebinyk A., Prylutska S., Grebinyk S., Prylutskyy Y., Ritter U., Matyshevska O., Dandekar T., Frohme M. Complexation with C60 fullerene increases doxorubicin efficiency against leukemic cells in vitro. Nanoscale Res. Lett. 2019. 14: 61. https://doi.org/10.1186/s11671-019-2894-1
32. Grebinyk A., Prylutska S., Grebinyk S., Ponomarenko S., Virych P., Chumachenko V., Kutsevol N., Prylutskyy Y., Ritter U., Frohme M. Drug delivery with a pH-sensitive star-like dextran-graft polyacrylamide copolymer. Nanoscale Adv. 2022. 4: 5077. https://doi.org/10.1039/D2NA00353H
33. Fabrication and Self-Assembly of Nanobiomaterials. Applications of Nanobiomaterials. Edited by Grumezescu A.M. (Elsevier Inc., 2016). P. 485.
34. Surface Chemistry of Nanobiomaterials. Applications of Nanobiomaterials. Edited by Grumezescu A.M. (Elsevier Inc., 2016). P. 528.
35. Kianfar E. Magnetic nanoparticles in targeted drug delivery: a review. J. Supercond. Novel Magn. 2021. 34(7): 1709. https://doi.org/10.1007/s10948-021-05932-9
36. Heidaripour A., Panahi H., Attari G., Jahansooz F. Fabrication of nanocomposite of HAp-SiO2-Fe3O4 suitable for magnetic hyperthermia. J. Med. Nanomater. Chem. 2024. 6(4): 251.
37. Adul-Rasool A.A., Athair D.M., Zaidan H.K., Rheima A.M., Al-Sharify Z.T., Mohammed S.H. 0, 1, 2, 3D nanostructures, types of bulk nanostructured materials, and drug nanocrystals: an overview. Cancer Treatm. Res. Commun. 2024, 40: 100834. https://doi.org/10.1016/j.ctarc.2024.100834
38. Zhou T., Igawa K., Kasai T., Sadahira T., Wang W., Watanabe T., Bekku K., Katayama S., Iwata T., Hanafusa T., Xu A., Araki M., Michiue H., Huang P. The current status and novel advances of boron neutron capture therapy clinical trials. Am. J. Cancer Res. 2024. 14(2): 429. https://doi.org/10.62347/HBBE6868
39. Advances in boron neutron capture therapy. (Vienna: IAEA, 2023). P. 416.
40. Jin H., Seldon C., Butkus M., Sauerwein W., Giap H.B. A Review of Boron Neutron Capture Therapy: Its History and Current Challenges. International Journal of Particle Therapy. 2022. 9(1): 71. https://doi.org/10.14338/IJPT-22-00002.1
41. Crossley E.L., Ching H.Y.V., Ioppolo J.A., Rendina L.M. Chapter 10. Boron and Gadolinium in the Neutron Capture Therapy of Cancer. In Book: Bioinorganic Medicinal Chemistry. Wiley?VCH Verlag GmbH & Co. KGaA 2011. P. 283. https://doi.org/10.1002/9783527633104.ch10
42. Photodynamic therapy. National Cancer Institute. 2020.
43. Kianfar E. Magnetic nanoparticles in targeted drug delivery: a review. J. Supercond. Novel Magn. 2021. 34(7): 1709. https://doi.org/10.1007/s10948-021-05932-9
44. Mushtaq A., Zhao R., Luo D., Dempsey E., Wang X., Iqbal M.Z., Kong X. Magnetic Hydroxyapatite Nanocomposites: The Advances From Synthesis to Biomedical Applications. Mater. Des. 2021. 197: 109269. https://doi.org/10.1016/j.matdes.2020.109269
45. Dynnyk O.B., Zalesskyi V.N. Molecular medicine: transformation of intracellular relocation processes of photosensitizers as a reserve for the effectiveness of their photocytotoxic action. Ukrainskyi medychnyi chasopys. 2005. 1(45). [in Ukrainian].
46. Hsieh Y.J., Wu C.C., Chang C.J., Yu J.S. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J. Cell. Physiol. 2003. 194(3): 363. https://doi.org/10.1002/jcp.10273
47. Konan Y.N., Berton M., Guniy R., Alleraam E. En hanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 2003. 18(3-4): 241. https://doi.org/10.1016/S0928-0987(03)00017-4
48. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug. Deliv. Rev. 2008. 60(15): 1627. https://doi.org/10.1016/j.addr.2008.08.003
49. Abodunrin T.O., God'shelp O.E., Owoeye F.D., Johnson O.A., Adeyemi O.S. Metal organic frameworks in photodynamic therapy of cancer: functional roles of active Metal centers, integrated and loaded photosensitizers in the ramework. Mater. Adv. 2025. 6. 1554. https://doi.org/10.1039/D4MA00425F
50. Niculescu A.-G., Grumezescu A.M. Photodynamic Therapy-An Up-to-Date Review. Appl. Sci. 2021. 11(8): 3626. https://doi.org/10.3390/app11083626
51. Shah D., Eroy M., Fakhry J., Moffat A., Fritz K., Cole H.D., Cameron C.G., McFarland S.A., Obaid G. Enabling In vivo optical imaging of an osmium photosensitizer by micellar formulation. Pharmaceutics. 2022. 14(11): 2426. https://doi.org/10.3390/pharmaceutics14112426
52. Prabha S., Vijay A.K., Mathew D.E., George B. Light sensitive orange carotenoid proteins (OCPs) in cyanobacterial photoprotection: evolutionary insights, structural-functional dynamics and biotechnological prospects. Arch. Microbiol. 2025. 207(2): 32. https://doi.org/10.1007/s00203-024-04215-w
53. Martella E., Dozza B., Ferroni C., Obeyok C.O., Guerrini A., Tedesco D., Manet I., Sotgiu G., Columbaro M., Ballestri M., Martini L., Fini M., Lucarelli E., Varchi G., Duchi S. Two Beats one: osteosarcoma therapy with light-activated and chemo-releasing keratin nanoformulation in a preclinical mouse model. Pharmaceutics. 2022. 14(3): 677. https://doi.org/10.3390/pharmaceutics14030677
54. Al-Jamal A.N., Al-Hussainy A.F., Mohammed B.A., Abbas H.H., Kadhim I.M., Ward Z.H., Kar Mahapatra D., Joseph T.M., Kianfari E., Thomas S. Photodynamic Therapy (PDT) in drug delivery: Nano-innovations enhancing treatment outcomes. Health Sciences Review. 2025. 14: 100218. https://doi.org/10.1016/j.hsr.2025.100218
55. Medical chemistry and clinical application of silicon dioxide. Edited by A.A. Chuiko. (Kyiv: Naukova dumka, 2003). P. 416. [in Russian].
56. Surface Physics and Chemistry. Book II. Surface Chemistry. Edited by Kartel N.T. and Lobanov V.V. (Kyiv: Chuiko Institute of Surface Chemistry, 2018). V. 1. [in Russian].
57. Surface Physics and Chemistry. Book II. Surface Chemistry. Edited by Kartel N.T. and Lobanov V.V. (Kyiv: Chuiko Institute of Surface Chemistry, 2018). V. 2. [in Russian].
58. Surface Physics and Chemistry. Book II. Surface Chemistry. Edited by Kartel N.T. and Lobanov V.V. (Kyiv: Chuiko Institute of Surface Chemistry, 2018). V. 3. [in Russian].
59. Jo S.D., Ku S.H., Won Y.Y., Kim S.H., Kwon I.C. Targeted nanotheranostics for future personalized medicine: recent progress in cancer therapy. Theranostics. 2016. 6(9): 1362. https://doi.org/10.7150/thno.15335
60. Obaid G., Broekgaarden M., Bulin A.-L., Huang H.-C., Kuriakose J., Liu J., Hasan T. Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale. 2016. 8(25): 12471. https://doi.org/10.1039/C5NR08691D
61. Fan W., Yung B., Huang P., Chen X. Nanotechnology for multimodal synergistic cancer therapy. Chem. Rev. 2017. 117(22): 13566. https://doi.org/10.1021/acs.chemrev.7b00258
62. Dujardin C., Auffray E., Bourret-Courchesne E., Dorenbos P., Lecoq P., Nikl M., Vasil'ev A., Yoshikawa A., Zhu. R.-Y. Needs, trends, and advances in inorganic scintillators. IEEE Transactions on Nuclear Science. 2018. 65(8): 1977. https://doi.org/10.1109/TNS.2018.2840160
63. Algorri J.F., Ochoa M., Rold?n-Varona P., Rodr?guez-Cobo L., L?pez-Higuera J.M. Light technology for efficient and effective photodynamic therapy: a critical review. Cancers. 2021. 13(14): 3484. https://doi.org/10.3390/cancers13143484
64. Yan J., Li B., Yang P., Lin J., Dai Y. Progress in light?responsive lanthanide nanoparticles toward deep tumor theranostics. Adv. Funct. Mater. 2021. 31(42): 2104325. https://doi.org/10.1002/adfm.202104325
65. Yang X., Gao L., Guo Q., Li Y., Ma Y., Yang J., Gong C., Yi C. Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy. Nano Res. 2020. 13(10): 2579. https://doi.org/10.1007/s12274-020-2722-z
66. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials. 2011. 32(4):1110. https://doi.org/10.1016/j.biomaterials.2010.09.069
67. Yang D., Kang X., Ma P., Dai Y., Hou Z., Cheng Z., Lin J. Hollow structured upconversion luminescent NaYF4:Yb3+, Er3+ nanospheres for cell imaging and targeted anti-cancer drug delivery. Biomaterials. 2013. 34(5): 1601. https://doi.org/10.1016/j.biomaterials.2012.11.004
68. Alves L.A., Ferreira L.B., Pacheco P.F., Mendivelso E.A.C., Teixeira P.C.N., Faria R.X. Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators. Oncotarget. 2018. 9(38): 25342. https://doi.org/10.18632/oncotarget.25150
69. Horbatok K., Makhnii T., Kosach V., Danko V., Kovalenko A., Fatiushchenkov S., Borysko P., Pishel I., Babii O., Ulrich A.S., Schober T., Afonin S., Komarov I.V. In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology. J. Visualized Exp. 2023. 29(199): e64902. https://doi.org/10.3791/64902
70. Sarabando S.N., Palmeira A., Sousa M.E., Faustino M.A.F., Monteiro C.J.P. Photomodulation Approaches to Overcome Antimicrobial Resistance. Pharmaceuticals. 2023. 16(5): 682. https://doi.org/10.3390/ph16050682
71. Ma X., Johnson D.A., He X.J., Layden A.E., McClain S.P., Yung J.C., Rizzo A., Bonaventura J., Banghart M.R. In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior. Nat. Methods. 2023. 20(5): 682. https://doi.org/10.1038/s41592-023-01819-w
72. Jia S., Sletten E.M. Spatiotemporal Control of Biology: Synthetic Photochemistry Toolbox with Far-Red and Near-Infrared Light. ACS Chem. Biol. 2022. 17: 3255. https://doi.org/10.1021/acschembio.1c00518
73. Paoletti P., Ellis-Davies G.C.R., Mourot A. Optical control of neuronal ion channels and receptors. Nat. Rev. Neurosci. 2019. 20(9): 514. https://doi.org/10.1038/s41583-019-0197-2
74. Tang Y., Hu J., Elmenoufy A.H., Yang X. Highly Efficient FRET System Capable of Deep Photodynamic Therapy Established on X-ray Excited Mesoporous LaF3:Tb Scintillating Nanoparticles. ACS Appl. Mater. Interfaces. 2015. 7(22): 12261. https://doi.org/10.1021/acsami.5b03067
75. Kusyak A., Petranovska A., Oranska O., Turanska S., Shuba Ya., Kravchuk D., Kravchuk L., Sotkis G., Nazarenko V., Kravchuk R., Dubok V., Bur'yanov O., Chornyi V., Sobolevs'kyy Yu., Gorbyk P. Chapter 3. Synthesis and Properties of Nanodispersed Luminescent Structures Based on Lanthanum Fluoride and Phosphate for Optopharmacology and Photodynamic Therapy of Tumor Diseases Localized in Cranial Organs and Bone Tissues. What to Know about Lanthanum. Catherine C. Bradley (Editor). (Nova Science Publishers, NY, USA, 2023).
76. Kusyak P., Shchehlov O.D., Oranska O.I., Kravchuk R.M., Gorbyk P.P. Nanodispersed X-Ray Phosphors LaF3:Tb3+, LaPO4:Tb3+, Hydroxyapatite:Tb3+:Obtaining and Ray Luminescence Properties. Theor. Exp. Chem. 2025. 60: 403. https://doi.org/10.1007/s11237-025-09842-y
77. Chien H.-W., Huang C.-H., Yang C.-H., Wang T.-L. Synthesis, Optical Properties, and Sensing Applications of LaF3:Yb3+/Er3+/Ho3+/Tm3+ Upconversion Nanoparticles. Nanomaterials 2020. 10(12): 2477. https://doi.org/10.3390/nano10122477
78. Jin X., Zhuang J., Zhang Z., Guo H., Tan J. Hydrothermal synthesis of hydroxyapatite nanorods in the presence of sodium citrate and its aqueous colloidal stability evaluation in neutral pH. J. Colloid Interface Sci. 2015. 443: 125. https://doi.org/10.1016/j.jcis.2014.12.010
79. Wang C., Jeong K.-J., Kim J., Kang S.W., Kang J., Han I.H., Lee Il-W., Oh S.-J., Lee J. Emission-tunable probes using terbium(III)-doped self-activated luminescent hydroxyapatite for in vitro bioimaging. J. Colloid Interface Sci. 2021. 581(A): 21. https://doi.org/10.1016/j.jcis.2020.07.083
80. Chen Y., Gu W., Pan H., Jiang Sh., Tang R. Stabilizing amorphous calcium phosphate phase by citrate adsorption. CrystEngComm. 2014. 16(10): 1864. https://doi.org/10.1039/C3CE42274G
81. Caldorera-Moore M., Guimard N., Shi L., Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin. Drug Deliv. 2010. 7(4): 479. https://doi.org/10.1517/17425240903579971
82. Danaei M., Dehghankhold M., Ataei S., Davarani F.H., Javanmard R., Dokhani A., Khorasani S., Mozafari M.R. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018. 10(2): 57. https://doi.org/10.3390/pharmaceutics10020057
83. Yan B., Gu J., Xiao X. LnPO4: RE3+ (La = La, Gd; RE = Eu, Tb) nanocrystals: solvo-thermal synthesis, microstructure and photoluminescence. J. Nanopart Res. 2010. 12: 2145. https://doi.org/10.1007/s11051-009-9776-x
84. Labrador-P?ez L., Kostiv U., Widengren J., Liu H. Water: An Influential Agent for Lanthanide-Doped Luminescent Nanoparticles in Nanomedicine. Opt. Mater. 2023. 11: 2200513. https://doi.org/10.1002/adom.202200513
85. Devi N., Ray S.S. Electromagnetic interference cognizance and potential of advanced polymer composites toward electromagnetic interference shielding: A review. Polym. Eng. Sci. 2022. 62(3): 591. https://doi.org/10.1002/pen.25876
86. Narayanan S.N., Jetti R., Kesari K.K., Kumar R.S., Nayak S.B., Bhat P.G. Radiofrequency electromagnetic radiation-induced behavioural changes and their possible basis. Environ. Sci. Pollut. Res. 2019. 26(30): 30693. https://doi.org/10.1007/s11356-019-06278-5
87. Wang H., Li S., Liu M., Li J., Zhou X. Review on Shielding Mechanism and Structural Design of Electromagnetic Interference Shielding Composites. Macromol. Mater. Eng. 2021. 306(6): 2100032. https://doi.org/10.1002/mame.202100032
88. Kumar D., Moharana A., Kumar A. Current trends in spinel based modi?ed polymer composite materials for electromagnetic shielding. Mater. Today Chem. 2020. 17: 100346. https://doi.org/10.1016/j.mtchem.2020.100346
89. Almessiere M.A., Slimani Y., Trukhanov A.V., Sadaqat A., Korkmaz A.D., Algarou N.A., Ayd?n H., Baykal A., Toprak M.S. Review on functional bi-component nanocomposites based on hard/soft ferrites: Structural, magnetic, electrical and icrowave absorption properties. Nano-Struct. Nano-Objects. 2021. 26(8): 100728. https://doi.org/10.1016/j.nanoso.2021.100728
90. Chang J., Zhai H., Hu Z., Li J. Ultra-thin metal composites for electromagnetic interference shielding. Composites, Part B. 2022. 246: 110269. https://doi.org/10.1016/j.compositesb.2022.110269
91. Wei H., Yu Y., Jiang F., Xue J., Zhao F., Wang Q. Carbon@SiC(SiCnws)-Sc2Si2O7 ceramics with multiple loss mediums for improving electromagnetic shielding performance. J. Eur. Ceram. Soc. 2022. 42(5): 2274. https://doi.org/10.1016/j.jeurceramsoc.2021.12.067
92. Bhingardive V., Woldu T., Biswas S., Kar G.P., Thomas S., Kalarikkal N., Bose S. Microwave Absorption in MWNTs-Based Soft Composites Containing Nanocrystalline Particles as Magnetic Core and Intrinsically Conducting Polymer as a Conductive Layer. Chem. Select. 2016. 1(15): 4747. https://doi.org/10.1002/slct.201601056
93. Hosseini S.H., Moghimi A., Moloudi M. Magnetic, conductive, and microwave absorption properties of polythiophene nano?bers layered on MnFe2O4/Fe3O4 core-shell structures. Mater. Sci. Semicond. Process. 2014. 24: 272. https://doi.org/10.1016/j.mssp.2014.02.046
94. Mazurenko R., Prokopenko S., Godzierz M., Hercog A., Makhno S., Szeluga U., Gorbyk P., Trzebicka B., Kartel M. Synthesis of nanosized spinel ferrites MnFe2O4 on the surface of carbon nanotubes for the creation of polymer composites with enhanced microwave absorption capacity. Appl. Mater. Today. 2023. 35: 101972. https://doi.org/10.1016/j.apmt.2023.101972
95. Mazurenko R., Prokopenko S., Godzierz M., Hercog A., Kobyliukh A., Gunja G., Makhno S., Szeluga U., Gorbyk P., Trzebicka B. Polymer Nanocomposites Based on Nanosized Substituted Ferrites (NiZn)1?xMnxFe2O4 on the Surface of Carbon Nanotubes for Effective Interaction with High-Frequency EM Radiation. Materials. 2024. 17(5): 986. https://doi.org/10.3390/ma17050986
96. Kusyak A.P., Kusyak N.V., Oranska O.I., Kulyk T.V., Dzubenko L.S., Palianytsia B.B., Dudarko O.A., Korniichuk N.M., Petranovska A.L., Gorbyk P.P. Magnetosensitive Nanocomposite Fe3O4/Al2O3/C Synthesis and Properties. Nanosystems, Nanomaterials, Nanotechnologies. 2023. 21(2): 0427.
97. Makhno S., Wan X., Lisova O., Gorbyk P., Wang D., Tang H., Shi Y., Kartel M., Ivanenko K., Hozhdzinskyi S., Zaitseva G., Stetsenko M., Sementsov Y. Conducting Rubber Anisotropy of Electrophysical and Mechanical Properties. Polymers. 2025. 17(4): 492. https://doi.org/10.3390/polym17040492
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 P.P. Gorbyk, S.M. Makhno, O.M. Lisova, A.P. Kusyak, R.V. Mazurenko, S.L. Prokopenko, N.V. Kusyak, I.V. Dubrovin, S.P. Turanska, A.L. Petranovskaya, H.M. Hunia, O.M. Shcheglov
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
